Apoptosis-regulating proteins and prognosis in diffuse large B cell non-Hodgkin's lymphomas

Acta Haematologica

Volumn 107, Issue 1, 2002, Pages 29-34

  Pagnano, K B B ^a   Silva, M D ^a   Vassallo, J ^a   Aranha, F J P ^a   Saad, Sara T O ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Bak; Bax; Bcl 2; Mcl 1; Non Hodgkin's lymphoma; p53; Prognosis

Indexed keywords

PARAFFIN; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN MCL 1; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL ASSESSMENT; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036288982     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046626     Document Type: Article

References (38)

1. Non-Hodgkin's lymphoma time trends: United States and international data
2. Changing trends in the incidence of non-Hodgkin's lymphoma in Europe
3. A predictive model for aggressive non-Hodgkin's lymphoma
4. Bcl-2, Bcl-X, Bax and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas
5. Prognostic significance of Bax protein expression in diffuse aggressive non-Hodgkin's lymphoma
6. New members of the Bcl-2 family and their protein partners
7. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death
8. Interactions among members of the Bcl-2 protein family analysed with a yeast two-hybrid system
9. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax
10. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases
11. Bax-deficient mice with lymphoid hyperplasia and male germ cell death
12. Bax suppresses tumorigenesis and stimulates apoptosis in vivo
13. Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphomas
14. Clinical significance of bcl-2 and p53 expression in diffuse large B-cell lymphoma: A population-based study
15. Prognostic significance of Bcl-2 protein expression and bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma
16. Relationship of p53, bcl-2 and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas
17. p53 enhances Bak and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis
18. Up-regulation of the proapoptotic mediators Bax and Bak after adenovirus-mediated p53 gene transfer in lung cancer cells
19. The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations
20. Correlation between mutation in p53, p53 expression, cytogenetics, histologic type and survival in patients with B-cell non-Hodgkin's lymphoma
21. Expression of p53 predicts treatment failure in aggressive non-Hodgkin's lymphomas
22. Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma
23. p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas
24. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group
25. Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: Meta-analysis of randomised studies comparing third generation regimens with CHOP
26. Use of avidin-biotin-peroxidase complex (ABC) in immunoper-oxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
27. Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins
28. Hydrogen peroxide-induced apoptosis mediated by p53 protein in glial cells
29. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: Correlations with in vitro and in vivo chemoresponses
30. Apoptosis-associated proteins and the development of oral squamous cell carcinoma
31. Reduced expression of proapoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma
32. Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1 and Bax in tumors of central and peripheral nervous system origin
33. Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
34. Loss of Bax expression is frequently seen in Burkitt's lymphoma biopsies and may result from null mutations in the Bax gene
35. Immunodection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infection
36. MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes
37. Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: A british national lymphoma investigation study
38. Clinical relevance of BCL2, BCL6 and MYC rearrangements in diffuse large B-cell lymphoma